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ABSTRACT
Understanding the prevalence and types of antibiotics used in a given human and/or animal
population is important for informing stewardship strategies. Methods used to capture such
data often rely on verbal elicitation of reported use that tend to assume shared medical
terminology. Studies have shown the category ‘antibiotic’ does not translate well linguistically
or conceptually, which limits the accuracy of these reports. This article presents a ‘Drug Bag’
method to study antibiotic use (ABU) in households and on farms, which involves using
physical samples of all the antibiotics available within a given study site. We present the
conceptual underpinnings of the method, and our experiences of using this method to
produce data about antibiotic recognition, use and accessibility in the context of anthro-
pological research in Africa and South-East Asia. We illustrate the kinds of qualitative and
quantitative data the method can produce, comparing and contrasting our experiences in
different settings. The Drug Bag method can produce accurate antibiotic use data as well as
provide a talking point for participants to discuss antibiotic experiences. We propose it can
help improve our understanding of antibiotic use in peoples’ everyday lives across different
contexts, and our reflections add to a growing conversation around methods to study ABU
beyond prescriber settings, where data gaps are currently substantial.
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Background
In response to rising concerns around antimicrobial
resistance (AMR), the WHO’s [1] Global Action Plan
has called for improved understanding and surveillance
of antibiotic use (ABU) in human and animal popula-
tions. In low- and middle-income countries (LMICs),
where much of the recent growth in ABU has occurred,
themost citedmethods andmetrics to shed light onABU
come frommacro-level consumption data from sales and
imports [2,3] and from prescriber settings, especially
hospitals [4]. However, to be able to ascertain the risks
of ABU for AMR in different scenarios, and therefore to
guide investment into efforts to curb AMR through
reducing ABU, fine-tunedmethods are needed to under-
stand how much and which antibiotics are being used
and by whom outside formal healthcare settings.
Currently there is no agreed protocol for collecting
such data at the local level, which is particularly impor-
tant in countries with active informal healthcaremarkets.
In a recent review of ABU data collection methods,
Queenan, Chandler and Goodman [5] found that most
household surveys relied upon respondent recall and
inventories of antibiotics kept at home – sometimes
aided by the use of show-cards – while farm surveys
utilised various combinations of recall, treatment logs
and packaging-bin searches. Among the challenges
faced by surveys is that recall is notoriously unreliable
[6] and inventories are restricted by what is actually kept
at home. In addition, surveys usually take place at a single
time point, affecting reliability of data collected due to
respondents having limited time to get to know the
reasons for the research [7,8] as well as the ability for
snapshot data to reflect wider trends and issues, for
example in illness episodes [9]. For ABU surveys, these
challenges are compounded by the fact that ‘antibiotic’ is
a broad and complex category that includes numerous
medicines and classes with long names and in some
scenarios substantial brand variation. Moreover, it is
often assumed in surveys that respondents recognise
antibiotics according to biomedical concepts and cate-
gories [10] when in fact theymay not use notions such as
‘bacteria’, ‘antibiotic’ or ‘infectious disease’ at all [11].
Together, these challenges significantly limit the reliabil-
ity of data that ask verbally about ABU in a one-off
interaction.
Nonetheless, an understanding of ABU at the gran-
ular level is key for well-informed interventions and to
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avoid making assumptions about the prevalence and
nature of ABU. Ethnographic research, including
immersive and observation techniques, is ideal for
understanding why and how medicines are used, and
for capturing local categories of medicines and the
contexts of their use [12,13]. For example,
Muelenbroek found during fieldwork in Burkina Faso
that the meaning of medicines was symbolically tied to
objects and places in the body, making illness episodes
tangible and therefore treatable [12]. Survey methods
can complement ethnographic approaches – not for the
purpose of capturing ‘attitudes’, ‘beliefs’ or ‘culture’
[7,14,15] – but to understand the extent to which popu-
lations are using different antibiotics.
This article presents findings and experiences from
using what we call the ‘Drug Bag’ method, which we
have been using as part of household and farm sur-
veys in Africa and South-East Asia as a precursor to
or alongside ethnographic fieldwork. In the following,
we firstly discuss the methodological and conceptual
underpinnings of the method, before describing how
we have operationalised it using an electronic data
capture system. We then draw on preliminary find-
ings from projects in Zimbabwe, Malawi, Uganda and
Myanmar to show the various kinds of qualitative
and quantitative data that the method can produce.
We finally reflect upon the strengths and limitations
of the method, and how these can inform the conduct
of larger ABU surveys and more generally contribute
to the growing conversation around ABU data collec-
tion methods beyond prescriber settings.
Methodology
Approach
The Drug Bag method is a modified version of the
established anthropological method of ‘pile sorting’
and draws on increasing concern to engage in interview
methods that are not solely cerebral but that use physical
materials to stimulate a deeper conversation between
interviewer and interviewee [16,17]. Pile sorting was
originally designed for mapping ‘cultural domains’ and
involves asking people to sort things into piles based on
similar attributes [13]. Pile sorting has had wide appli-
cations within and beyond anthropology, including in
survey research [18]. In medical anthropology, it has
been used to study a range of themes such as illnesses,
medicines, norms, values and perceptions of risk [19–
22].What makes pile sorting useful for studying ABU is
its use of visual and/or material cues to assemble differ-
ent ‘piles’ based on predefined criteria. Our basic idea
was to disentangle pile sorting from the study of cultural
domains and repurpose its material and visual nature to
the more modest task of finding out, without assuming
that people deploy biomedical terms (e.g. ‘antibiotic’),
which antibiotics people recognise, use and can(not)
access. This engages the materiality of medicines [12]
to establish common referents with our respondents
that would allow us to build a bridge between ‘local’
and ‘global’ categories.
Implementation
We developed and piloted the Drug Bag method
within our ongoing ethnographic studies in Harare
in Zimbabwe, Chikwawa District in Malawi, Yangon
in Myanmar, and Kampala and Tororo in Uganda.
We conducted one study of ABU in the animal sec-
tor, involving a rural-urban comparison in Wakiso
District and Tororo, Uganda (see Table 1). Our
research teams carrying out the drug bag studies
comprised of social science research degree students
and experienced research assistants. Our objectives
for the drug bag exercises are presented in Box 1.
Figure 1 shows the various steps that we took while
assembling and operationalising our drug bags in our
different settings. In all study sites, we started by visiting
all spaces where antibiotics could be acquired, including
local clinics and hospitals, retail pharmacies, vets (for the
animal ABU survey), as well as iterant drug sellers and
market vendors. We generally started with providers
nearest to residential areas/farms, before moving further
afield until we had exhausted as many options as reason-
ably possible. We then bought as many different types of
antibiotics as we could, making sure to include differ-
ences in ingredients, appearance, brand name and mode
of administration to optimise recognition. In some
Table 1. Drug Bag participants.
Study Site (Region,
Country)
Human/animal
sector
Sample
Size
Mean Household
Size
Sex of main respondent (%
female)
Mean age and range of main
respondent
Harare, Zimbabwe Human 100 6 96 43 (18–81)
Chikwawa, Malawi Human 101 4.5 90 27 (17–71)
Yangon, Myanmar Human 50 5 92 47 (21–83)
Kampala, Uganda Human 174 - 79 -
Tororo and Wakiso,
Uganda
Animal 115 - 52 18–87
Box 1. Drug Bag Research Objectives.
(1) To establish how many, and which, different antibiotics were
recognisable by members of households and/or farmers in
a given study context
(2) To capture which antibiotics household members/farmers said
they used, and the approximate frequency of use
(3) To capture the symptoms and illnesses that frequently-used
antibiotics were used to treat.
(4) To capture which antibiotics were easier and harder to access
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surveys, we did include eye drops, ear drops and topical
creams. However, most emphasis on ABU data collec-
tion globally is on oral and injectable antibiotics [2], and
thus we restrict our data in this article to these modes of
administration. In most instances, the generic name was
included on the packaging, but where it was not a label
was added and/or respondents were informed of the
names as they examined the drugs. In our African set-
tings, we found between 40–60 antibiotics; in Myanmar,
we found well over 100, which reflects the larger market
for antibiotics in South-East Asia [23]. The antibiotics
were listed alphabetically, and each was assigned
a number from 1-n. This number was recorded on the
physical copy of each antibiotic via a sticker, such that we
ended up with a one-to-one correspondence between the
list and the drug bag.
We then designed a series of pile sorting exercises
involving the drug bags that were included within
household and farm surveys in our study settings (sur-
veys also included questions about common illnesses,
medicines and health seeking to contextualise antibiotic
use). Given the anthropological orientation of our
research, we did not design these surveys as self-
standing studies of ABU but rather a precursor to or
alongside longer-term ethnographic fieldwork. As
a result, it was not necessary in our work to calculate
statistically-defined sample sizes and generate widely
representative data, although the lessons we learned
could and indeed are being fed into the design and
conduct of larger surveys, including an ongoing survey
in Chikwawa, Malawi. Most surveys involved purposive
sampling of households or farms, with the aim of
•
•
Scope local formal 
and informal sectors 
for antibiotics
Purchase/acquire 
antibiotics available 
in the study setting 
Scope and acquire 
antibiotics
•
•
Produce alphabetic list of 
antibiotics and then 
number them sequentially
Place corresponding 
number stickers on all 
antibiotics
•Put everything into a large 
bag (e.g. backpack) ready 
for the field
Assemble and 
number the drug bag
•
•
Design a progressive 
sequence of pile sorting 
exercises (only one ‘pile’ 
per exercise)
Design a paper or tablet-
based form for recording 
responses to the pile 
sorting exercises and 
other survey questions
Prepare pile sorting 
exercises
•
•
Conduct exercises in 
homes and on farms 
using the drug bag 
and data collection 
forms/tablets
Use boxes, mats 
and other aides 
where necessary
Implement in homes 
and on farms
Figure 1. Steps taken to operationalise drug bags.
All medicines
Don’t recogniseRecognise
Used
All other 
recognised
Frequently 
used
All other 
used
Used in last 
30 days
All other 
used
All used meds
Discard
1
2
3
4
All recognised meds
Could not 
get medicine
All other 
recognised
5
Eliciting  
narratives of 
antibiotic 
recognition, use 
and access 
throughout 
Figure 2. Flow diagram showing the progression of pile sorting exercises.
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‘getting to know’ our study populations and sub-groups
within them. The exercises were pitched at the level of
the farm and/or household. Wanting to produce a rich,
holistic picture of ABU, there was usually a primary
respondent (e.g. household head or farm owner), but
we actively encouraged other present household/farm
members to join in with the exercises.
In order to keep the process as simple and reliable as
possible, the pile sorting exercises were designed to be
sequential, cumulative and only ever involve one ‘pile’
being created each time. The task of the first exercise was
to identify which of the large collection medicines in the
bag that respondents recognised and which they did not.
This normally enabled us to exclude the vast majority of
antibiotics, resulting in a smaller, more manageable
collection of antibiotics to be used for the remaining
exercises. While the ensuing exercises could have been
taken in a number of directions, our objectives (Box 1)
led us to ask respondents to pick out which ones they
had used before; which they used frequently in their
household when someone was sick; which they had
used in the last 30 days; and which they had at times
been prescribed or wanted but struggled to access
(Figure 2). The ‘piles’ were recorded on tablets using
Open Data Kit (ODK) (accessible at www.opendatakit.
org) and analysed quantitatively using R (accessible at
https://www.r-project.org). However, the data could also
have been collected on paper forms and entered subse-
quently into a computer database.
In order to capture the ‘hows’, ‘whys’ and ‘whens’ of
ABU – and to thereby qualify, substantiate or challenge
quantitative data – we elicited respondents’ narratives
throughout. They were encouraged to narrate why med-
icines were placed in certain piles, which illnesses ‘fre-
quently used’ medicines were used to treat, and any
stories that respondents had to tell about using (or
being unable to access) the medicines. To capture these
narratives, we either audio recorded the pile sorting
process or took detailed field notes. Thematic analysis
was then conducted on the data using NVivo 11. In
Malawi, where narrative data were not captured, we
found that the exercises took between 15–40 minutes
(Figure 3). With the narrative component included,
then depending on various factors including how talka-
tive people were, how much time they had available, and
any distractions, the exercises could take anything from
30 minutes to over two hours. A copy of one of the
versions of the medicines survey can be found here.
Findings of the Drug Bag method in action
Participants
We used the Drug Bag Method with five samples of
households and farms across our settings, as described
in Table 1. These numbers inform our analysis of the
utility of the method at the time of writing.
Did the Drug Bag method produce useful data on
antibiotic recognition?
During the design phase of our research, we queried
whether people would actually recognise many anti-
biotics, even when presented with physical examples
(objective 1). We found that at our African sites,
respondents recognised many of the antibiotics we
showed them, especially oral antibiotics (tablets, cap-
sules and suspensions). The antibiotics that most
commonly featured in the ‘recognised’ pile were peni-
cillins (especially amoxicillin), doxycycline, cotrimox-
azole, metronidazole, ciprofloxacin and
erythromycin. These antibiotics were generally those
that were available in primary healthcare facilities,
funded through donor programmes and/or available
in the informal sector. To exemplify, Figure 4 shows
our quantitative recognition data from Chikwawa
District, Malawi. Here amoxicillin and cotrimoxazole
tablets stand out in particular because, as we found,
these are often the only two stocked in primary
clinics. Across all of our sites, people tended to be
less familiar with injectable forms of antibiotic and
those more usually prescribed in hospital settings
(e.g. ceftriaxone). Nonetheless, we encountered
many people who recognised antibiotics that they or
others had been prescribed as inpatients. In the con-
text of farming in Uganda, meanwhile, the most
widely recognised antibiotics for poultry were tetra-
cyclines and sulfonamides, mostly in powder form
added to poultry drinking water, and salinomycine
included in purchased feeds. The types of antibiotics
remained the same for pigs, but in their case, inject-
ables were much more common.
In Myanmar, most respondents were familiar with
oral forms of amoxicillin and ampicillin. However,
beyond these, levels of recognition amongst our respon-
dents seemed low, and our researchers reported much
‘guessing’ by respondents, who often felt like they were
being tested. Low levels of recognition might be
Figure 3. Field team in Malawi practicing the pile sorting
exercises.
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surprising given the large informal health sector in
Myanmar, in which many antibiotics can be bought
without a prescription. However, as we found while
scoping for antibiotics (and as is widely documented in
South-East Asia [23]), drug shops often do not give drugs
in their original packaging but rather take them out and
provide a certain number of doses (often alongside other
medicines) in small plastic bags. With so many antibio-
tics looking the same or very similar, this meant that our
respondents were often unable to pick out even those
antibiotics to which they might be regularly exposed.
Although establishing recognition of medicines in
Myanmar was challenging, in all sites we paid close
attention to the way that respondents spoke with us
and each other and were able to ascertain not only
which antibiotics they recognised but how they recog-
nised them. In Zimbabwe, for instance, generic names
were shorthanded to ‘cipro’ (ciprofloxacin), ‘doxy’ (dox-
ycycline), ‘amoxyl’ (amoxicillin) and ‘cotri’ (cotrimoxa-
zole). But also, we saw branding and packaging
influencing local categories. For example, in Myanmar,
where there was considerable brand variation, one of the
antibiotics, an amoxicillin suspension often given to chil-
dren in the area, was referred to locally as the ‘jeep-car
medicine’ (Figure 5), because of the picture on the box.
Identifying local categories and terminologies was an
important starting point for exploring people’s relation-
ships with medicines and how knowledge is communi-
cated within and across formal and informal,
professional and popular sectors. It allows researchers
to move beyond technical terms and jargons that can
impede more open discussions of ABU.
Did the Drug Bag method produce useful ABU
data?
Upon the foundations of our recognition data, we began
to identify patterns of household and farm antibiotic use
within and between our research sites, as well as differ-
ences between them. One of the most important objec-
tives for orienting further fieldwork was to identify those
antibiotics that our respondents were using frequently
and that were making up the bulk of ABU (objective 2).
As we found, antibiotics placed in the ‘frequently used’
pile were also themost likely to have been usedwithin the
30 days prior to the survey. Among our respondents in
Harare, Zimbabwe, the most ‘frequently used’ antibioticsFigure 5. The ‘jeep-car medicine’ in Yangon, Myanmar.
Clindamycin injection
Amoxicillin/clav acid tablet
Azithromycin tablet
Clarithromycin tablet
Chloramphenicol injection
Cefalexin tablet
Clindamycin tablet
Cefixime tablet
Amoxicillin/flucloxacillin tablet
Cefuroxime tablet
Ofloxacin/ornidazole tablet
Metronidazole/norfloxacin tablet
Flucloxacillin tablet
Chloramphenicol tablet
Levofloxacin tablet
Ceftriaxone injection
Gentamicin injection
Benzylpenicillin injection
Tetracycline tablet
Cloxacillin tablet
Ampicillin tablet
Cloxacillin suspension
Benzathene penicillin injection
Doxycycline tablet
Metronidazole suspension
Erythromycin suspension
Cotrimoxazole suspension
Ciprofloxacin tablet
Metronidazole tablet
Erythromycin tablet
Penicillin V tablet
Amoxicillin suspension
Cotrimoxazole tablet
Amoxicillin tablet
0 25 50 75 100
Percentage of Households
Class
Aminoglycoside
Cephalosporine
Fluoroquinolone
Lincosamide
Macrolide
Nitroimidazole
Penicillin
Sulfonamide
Tetracycline
Other
Figure 4. Percentage (%) of respondents that recognised antibiotics available in Chikwawa District, Malawi (n = 101).
*Includes 34 antibiotics classified by generic name and mode of administration (and reclassified retrospectively by class). Tablets and capsules are
both labelled ‘tablet’.
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were amoxicillin, cotrimoxazole, doxycycline, metroni-
dazole, ciprofloxacin and erythromycin (the same as the
most recognised antibiotics), and on average this pile
contained 4.3 antibiotics. By contrast, in Chikwawa, the
pile contained on average only 1.2 antibiotics, usually
amoxicillin and/or cotrimoxazole. This was unsurprising
in this particular setting given the extremely limited
availability of antibiotics in the area. Uganda fell just
between Zimbabwe and Malawi, with 2.8 antibiotics in
the ‘frequently used’ pile, and metronidazole making up
26% of ABU, a markedly different pattern than in our
other sites. In Myanmar, the pile tended to be similarly
small with varying composition, but this is likely related
to the difficulties of establishing recognition. Figure 6
shows the proportional consumption of frequently-used
antibiotics by class in Malawi, Myanmar, Uganda and
Zimbabwe.
Respondents’ narratives provided a richer under-
standing of the illnesses that particular antibiotics were
used to treat (Objective 3), as well as how knowledge
about antibiotic use was acquired and shared. Picking
up antibiotics and conversing in animated tones among
one another, we found, for instance, that respondents in
Uganda used metronidazole to treat both a range of
stomach problems and chronic pain; that in Zimbabwe,
metronidazole was used along with ciprofloxacin or dox-
ycycline to treat STIs; that in Malawi, cotrimoxazole
given to HIV-positive individuals was often shared with
other household members when they were sick; and that
tetracycline powders were used by Ugandan farmers to
care for poultry with recurrent gastrointestinal and
respiratory conditions. ABU often followed attendance
at a clinic, hospital, or vet, sometimes involving
a prescription taken to a retail pharmacy. But knowledge
of antibiotic use also filtered from and circulated beyond
the formal sector, as old prescriptions and past experi-
ences were used to inform ABU or to guide purchasing
drugs through the informal sector. It was during these
lively discussions that we began to appreciate how effec-
tive the Drug Bag method was for provoking memories
and experiences of ABU and for helping us to understand
how, why and when different antibiotics were used in the
context of people’s everyday lives and livelihoods.
Did the Drug Bag method produce useful data on
antibiotic accessibility?
Given the precarious circumstances in which many of
the households and farmers across our study sites
lived and worked, it is impossible to understand
patterns of ABU without considering the accessibility
of different antibiotics (Objective 4). When respon-
dents were asked to pick out those antibiotics they
had ever needed before but been unable to access, we
found that some of the more expensive antibiotics
generally found in the hospital sector were placed in
this pile. For instance, in Harare, Zimbabwe, more
households reported having needed and being unable
to access vancomycin – a drug that costs upwards of
$30USD per day for hospital inpatients – than had
actually ever used the drug. But perhaps more impor-
tantly, even access to basic antibiotics appeared to be
highly temperamental. For example, amoxicillin, the
most widely-used antibiotic at the primary care level
globally, was also the most commonly placed in the
‘needed but could not access’ pile. Our respondents
further substantiated this by drawing attention to
long clinic queues, long distances needed to travel
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Figure 6. Proportional reported use (%) of frequently-used antibiotics by class among households in Malawi (n = 101), Myanmar
(n = 50), Uganda (n = 174) and Zimbabwe (n = 100).
6 J. DIXON ET AL.
to reach clinics, frequent stockouts, user fees and
extortionate pharmacy prices as common reasons
for non-access. With numerous socio-economic fac-
tors undermining people’s ability to access medicines
through the formal sector, for many, the informal
sector was often the only available option to them.
The main challenge of establishing the accessibility
of different antibiotics using our particular method
was that many of the drugs that we suspected would
be harder to access – e.g. later-generation cephalos-
porins or carbapenems – were sparsely recognised by
our respondents or not even included in the drug
bags at all. Speaking in terms of the WHO’s new
Access, Watch and Reserve (AWaRe) categories,
many of the more expensive antibiotics belong to
the ‘Watch’ or ‘Reserve’ groups. ‘Key Access’ antibio-
tics are those which should be ‘widely available,
affordable and quality-assured’; ‘Watch Group’ anti-
biotics are those with a higher resistance potential
and to be prioritized as key targets of stewardship
interventions; and ‘Reserve Group’ antibiotics are
‘last resort options’ [24, 8–9]. While the majority of
the antibiotics in our drug bags belonged to the
‘Access’ group, the bulk of the cost of putting
together the bags went into buying ‘Watch’ group
antibiotics, and we could only find two ‘Reserve’ list
antibiotics at all, both of which were in Myanmar.
Overall, we got a better picture of antibiotic avail-
ability through the process of assembling the bags,
hearing respondents talk about the inequities of the
health system and noting that the overwhelming
majority of ‘frequently-used’ drugs were on the
‘Access’ list. Even in Myanmar, where antibiotics
were cheaper and respondents rarely reported being
unable to get antibiotics when needed, we realised
that this was not equivalent to access to care.
Indeed, it seemed that accessing good quality care
was, if anything, more challenging than in Africa.
What unintended effects did the Drug Bag
method have?
Walking into people’s houses and farms with a large bag
of drugs that people were often either unfamiliar with or
were unable to access had unintended consequences.
Sometimes, respondents would ask to keep the drugs
that we had brought with us; people were sick, and we
had medicines that might help to make them better.
Moreover, the drug bags brought with them new ideas
and knowledge that was put to use, most evidently in our
Ugandan farm survey. For example, one respondent said
that she gained new knowledge during the survey which
she applied to her chicken farming:
When I saw her drugs … I didn’t know them. After,
I went to the vet and remembered the colour and
bought that drug. I researched it, tried out themedicine
on my chickens. They are now well. Even my neigh-
bours now they are wanting to use this medicine.
Another respondent’s cows were doing so well that
after that her neighbours stole them. As it transpired,
respondents were taking their own photos and notes
of unfamiliar medicines and buying them from drug
shops. This served as a stark reminder that, by bring-
ing people into contact with new medicines, we were
not simply ‘neutral’ observers but became active par-
ticipants, understood as ‘experts’, shaping antibiotic
knowledge and use. We return to the ethical and
methodological implications of these effects below.
Discussion
Understanding the prevalence and types of antibiotics
used in a given population is important for informing
interventions that attempt to control ABU. In low-
income settings where digital prescribing records
capture the minority of antibiotic prescriptions or
purchases, community-level data collection is
required to evaluate the local contours of ABU. This
paper presents methodological developments in the
assessment of antibiotic use through the ‘Drug Bag’
approach. An adaptation of ‘pile sorting’ [13], the
limitations of spoken surveys that rely on abstract
concepts of antibiotics are circumvented through
the material presentation of antibiotics that are then
sorted into piles according to the research questions.
Our accounts of piloting this approach in Zimbabwe,
Malawi, Uganda and Myanmar showcase the kinds of
data the method can produce as well as highlight its
strengths and limitations.
Logistics
Operationalising the drug bags took 2–5 weeks for our
field teams to complete, including scoping, purchasing,
and assembling the bags (Figure 1). Oral antibiotics
were generally very cheap, but some injectable medi-
cines cost up to USD30. The total cost of the drug bags
ranged between USD70 (Malawi) and USD350 (farm
drug bag, Uganda). While this was time and resource
intensive, we learned much about local pharmaceutical
markets along the way, which was valuable data in the
context of our broader project objectives. Indeed, aside
from the knowledge gained, we established relationships
with local sellers, several of whom since became
enrolled in ethnography.
In terms of implementation, using the Drug Bag
Method was not as time consuming as we had first
expected, because the initially large number of anti-
biotics tended to be whittled down to a manageable
few following the first recognition exercise. It was
also social and often fun for respondents, resulting
in high rates of interest in participating. Capturing
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qualitative data alongside the exercises took the long-
est and could take anywhere between 30 mins and
2 hours. In Malawi, where qualitative data were not
captured, we found this took 15–40 minutes. Future
studies could expand or adapt the pile sorting exer-
cises to answer particular research questions, and it
will fall to careful design and piloting work to deter-
mine what can be accomplished within the time
constraints of the research.
Assessing data quality against objectives
In terms of the utility of theDrug Bagmethod inmeeting
our objectives, establishing recognitionwasmost success-
ful at our African sites, where there was a relatively small
and stable range of antibiotics available. Recognition was
highest among oral antibiotics that are most commonly
available in public clinics, from vets and in the informal
sector. In Myanmar, although we were able to shed light
on the ways that people categorise and speak about
particular antibiotics, establishing patterns of recognition
wasmore challenging. As suggested above, this was likely
related to the large informal markets for antibiotics and
the way that medicines are bought and sold [11,23]. In
Myanmar, if the drug bags made one thing clear, it was
that perhaps we had started in the wrong place; if we
wanted to understand people’s relationships with medi-
cines, we had to understand their relationship with pro-
viders of antibiotics. Moreover, social scientists in
Myanmar [25,26] have noted that the country’s long
history of authoritarian rule has left many people highly
suspicious and fearful of unknown outsiders probing into
their lives. This is a political context that international
health research cannot easily escape: it made it very
difficult to establish trust and almost certainly affected
the way that people responded to the drug bags.
Where we arguably had the most success using the
Drug Bag method was in establishing which antibiotics
people were ‘frequently using’ at the household and farm
level (objective 2) and what those antibiotics were used to
treat (objective 3). The most frequently-used antibiotics
tended to be the most recognised and, particularly in our
African sites, we were encouraged by the confidence with
which people picked out and spoke about how, why and
when such antibiotics were used. While self-reported
‘frequent use’ by no means captures the full extent of
ABU, such categories offer a window into the local con-
tours of ABU beyond prescriber settings where data are
currently fewest. In order to shed further light on how
and why people use antibiotics the way they do, we also
used the drug bags to assess the accessibility of antibiotics
in different settings (objective 4). Our data on reported
accessibility was constrained by what people were able to
recognise within the drug bags, and thus we had limited
success with meeting objective 4. Nevertheless, we were
able to learnmore about antibiotic access and availability
from assessing what kinds of drugs people were (fre-
quently) using, where they got them from, and hearing
about the difficulties that people had accessing healthcare
in contexts of often-extreme poverty [27]. In sum, even if
reliable use data is restricted to a select few widely-
recognised, frequently-used antibiotics, understanding
thesemedicines and the contexts of their use is important
for designing targeted and context-specific interventions
to address AMR.
Ethical implications of the Drug Bags
Working with physical samples of antibiotics – material
objects with significance and value – raised a number of
ethical issues. Studies have shown that field workers
often play an under-acknowledged ethically-charged
role mediating between the interests and expectations
of researchers and study communities [28,29]. As we
showed, bringing these scarce commodities into people’s
homes sometimes generated expectations for medicines
and care, especially in more deprived settings. Although
our field teams did not feel unsafe in the field, they did
encounter some difficult situations. In consultation with
our field teams, we partially addressed the challenge by
removing the use-by dates on the antibiotics and inform-
ing respondents that the antibiotics had expired.
However, our teams still often felt compelled to help
people access care in cases of dire need, such as driving
them to the hospital or paying for transport ormedicines.
Social science scholarship emphasises the importance of
‘relational ethics’when engaging such dilemmas [28–30],
and thus in all of our surveys we have supported our field
Table 2. Observed strengths and limitations.
Strengths Limitations
Data – Establishing patterns of recognition in settings with
a relatively small and stable range of antibiotics
– Capturing ABU and approx. frequency of use
– Capturing symptoms and illnesses that freq. used antibiotics
were used to treat
– Unreliable data on recognition (and thus use/frequent use) in
settings with wide and shifting range of antibiotics
– Directly identifying antibiotics that are difficult to access
– Demonstration effects on ABU practices
Logistical – Establishing relationships with providers for ongoing
fieldwork
– Engaging and fun method, contributing to high recruitment
rates
– Time and resource intensive
Ethical – Takes seriously the importance of local categories, contexts
and concerns
– Generated expectations for medicines and care
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teams’ decision-making in the field, worked with them to
overcome ethical issues, and held regular debriefings.
It is also of ethical and methodological significance
that, by introducing people to antibiotics we had bought
locally ‘over the counter’, theDrug Bagmethodmay have
demonstration effects on ABU practices. Were we send-
ing people the ‘wrong message’ (e.g. that they should be
using antibiotics)? During the consent process, we care-
fully explained that we had brought these antibiotics for
research purposes to help respondents to remember any
medicines that they have already encountered. We also
explained that we were not medical/veterinary ‘experts’,
nor there to judge or impose certain values, but rather
social scientists interested in their opinions and experi-
ences. From an anthropological perspective, it is unsur-
prising that the drug bags nonetheless generated new
knowledge and practices: ethnographic research has
long shown that global health research inevitably shapes
the reality that it seeks to represent [31–33]. From
a relational ethics perspective, we did not consider it
problematic that some respondents, most living with
limited access to medicines and/or care, gained knowl-
edge thatmight have been useful for themselves and their
families. However, this could well affect the reliability of
ABU data, especially in the context of farming where we
found the most examples of altered practices, and
researchers seeking greater impartiality may seek ways
of mitigating such effects.
Table 2 summarises the strengths and limitations
of the method highlighted above.
Considerations for larger surveys
In our anthropological surveys, the Drug Bag method
was used primarily as a way of identifying themes and
questions to be followed up ethnographically and was
therefore more of a starting point than an end in and of
itself. The potential to use this method to capture more
widely generalisable ABU data rests on the following
considerations. First, broadening the geographical scale
requires compiling drug bag contents that are locally
relevant but not too numerous. Compiling different
bags according to locale may be required but raises
challenges of comparability, unless the bags hold con-
stant the same ingredients and modes of administration,
while allowing considerable differences in brand and
appearance. To avoid the problem of too many drugs
in the bag, a smaller range of antibiotics could be
included and the objectives narrowed to interest in par-
ticular types of medicines. Such targeted drug bags could
also be more appropriate in settings where large, rapidly
shifting markets for antibiotics makes for very large,
unwieldy drug bags (as was the case in Myanmar).
Given the centrality in this method of establishing recog-
nition, data are likely to be more accurate if more/all
versions of fewer antibiotic types are included than a few
versions of more antibiotics.
Second, when designing survey contents, our experi-
ence points to the importance of including fewer, well-
tested questions that can produce reliable data.
Consideration for expanding this method should show
caution in adding further questionnaire modules which
are ill-suited to survey methodology – for example to
capture phenomena such as ‘attitudes’, ‘beliefs’ and ‘cul-
ture’ [7,14,15]. To attempt this risks misleading ABU
data and potentially reinforcing decontextualized ima-
ginings of ‘irrational’ end users [27]. We recommend
that understanding context is essential but that this
requires other methods. Third, and relatedly, fieldwor-
kers must feel empowered to report their experiences
and challenges through the research process. Data inter-
pretation relied on hearing about the how people
engaged with the drug bags, which was made easier
given the inbuilt qualitative component in most of our
surveys. But in the context of larger surveys, qualitative
data might not be collected, and thus it is all the more
important to ensure feedback loops with researchers
insulated from the ‘noise’ of the field. As discussed
above in relation to ethics, field workers are a valuable
and yet chronically undervalued resource in global health
research, and their inclusion in data interpretation is
crucial in this complex field of study. Finally, if this
method were to be scaled up it would be valuable to
compare it with othermethodologies such as show cards,
and consider whether the value of the data generated
from the drug bag is worth the cost involved when
carrying out a large-scale survey, or indeed whether
there might be a role for the drug bag method earlier
on in the design of tools for a larger scale survey.
Conclusions
In this article, we presented findings and reflections from
using the Drug Bag method to study ABU at the house-
hold and farm level in low-income settings. Overall, we
found the method a useful way of commencing ethno-
graphic research and have considered the wider applic-
ability of the method for survey-based research. Further
detailed comparison is needed to ascertain how and
under what circumstances the method should be used
instead of, or in conjunction with, other tools.
Furthermore, careful thought is needed to decide how
household ABU metrics should be collected and inter-
preted in relation to data collected at other levels, includ-
ing provider and macro consumption data. We share
these findings to add to the growing conversation about
ABUdata collectionmethods in spaces beyondprescriber
settings where data are fewest and challenging to collect.
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